Ignite Creation Date:
2025-12-25 @ 3:29 AM
Ignite Modification Date:
2026-04-24 @ 8:35 AM
Study NCT ID:
NCT00336505
Status:
COMPLETED
Last Update Posted:
2010-02-26
First Post:
2006-06-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study Comparing the Safety and Efficacy of Cethromycin to Clarithromycin for the Treatment of Community-Acquired Pneumonia (CAP)
Sponsor:
Advanced Life Sciences, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CL05-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
David Eiznhamer, PhD, Executive Vice President, Clinical Development
Old Organization:
Advanced Life Sciences